|
Buteyko
Breathing Techniques in Asthma: a blinded randomized controlled
trial Design: Prospective, blinded, randomized study comparing the effect of Buteyko breathing techniques with control classes in 39 people with asthma. The study was conducted from January 1995 to April 1995. Participants: Subjects recruited from the community, aged 12 to 70 years, with asthma and substantial medication usage.
Conclusion:
Those practicing Buteyko breathing techniques reduced hyperventilation
and their use of reliever medications (beta2-agonists ) and preventers
(inhaled steroids). Participants in the Buteyko group showed improved
scores for Quality of Life whilst the Control group saw no significant
improvements in either hyperventilation, medication usage or Quality
of Life. Prevalence
of dysfunctional breathing in patients treated for asthma in primary
care: a cross sectional survey Summary Objectives: To estimate the prevalence of dysfunctional breathing in adults with asthma treated in the community. Design: Postal questionnaire survey using Nijmegen questionnaire Setting: One general practice with 7033 patients. Participants: All adult patients aged 17-65 with diagnosed asthma who were receiving treatment. Main outcome score: Score greater than or equal to 23 or Nijmegen questionnaire.
Conclusions:
About a third of women and a fifth of men had scores suggestive
of dysfunctional breathing. Although further studies are needed
to confirm the validity of this screening tool and these findings,
these prevalence suggest scope for therapeutic intervention and
may explain the anecdotal success of the Buteyko method of treating
asthma. Dr Patrick
Mc Hugh BMed Sc, MBChB, Dip GUMed, Dip MSM Buteyko Institute Method Techniques for Controlling Asthma Commencement date: 6.3.2000 Testing completed September 2000
Design:
A randomized, double blind trial, with the Buteyko group learning
the Buteyko Institute Method as taught by Buteyko New Zealand. Participants: Forty participants were selected for inclusion and were matched and randomly assigned to either Buteyko or control groups.
The trial: included seven sessions of instruction. Four sessions in the first week, two sessions in the second week and one session in the third week.
At three months and again at six months, testing of FEV1, ETCO2 and QOL measurements were carried out for both groups. Results: results are currently being analyzed and report compiled. An interim report, regarding this trial, was delivered by DR Patrick McHugh to the delegates of the BIBH International Conference, Hastings New Zealand December 2000. Hamilton Polytechnic, New Zealand, pilot study, 1999 Victoria University, Victoria Australia. (Cameron Gosling, Steve Lee). BIBH (Paul O'Connell), 1999 This information provided courtesy of the Buteyko Institute of Breathing and Health (BIBH). [Buteyko Method] [Buteyko Research] [Buteyko Articles] |
Kick
Asthma®, LLC Tel
206-763-8882 The
information and techniques presented on this website do not constitute
medical treatment. You should consult your health care provider
before trying the techniques presented on this site and before modifying
any medication prescribed to you. Kick Asthma®, LLC makes no
guarantees or warranties about results you may experience as a result
of the techniques presented on this website or in products sold
from this website. Kick Asthma®, LLC is not liable or responsible
for any damage caused or alleged to be caused, either directly or
indirectly, by the information contained on this website or products
for sale on this website. © Copyright 2000-2006, Kick Asthma®, LLC. All rights reserved. Website development by New Tech Web, Inc.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||